Sorry, you need to enable JavaScript to visit this website.

Clinical Study Report Synopses

Clinical Study Reports (CSRs) are often created as part of the process of submitting applications for new medical treatments to regulators. CSRs answer questions such as: Why was the trial done? What were the important questions asked in the trial? What were the results? CSRs also include extensive details on the course of treatment for patients, the medical information collected from the patients as part of the research, and demographic data, as well as other kinds of information to explain how the trial was conducted and results were analyzed.

Because CSRs contain information that could be valuable to researchers, Pfizer is making electronic synopses of CSRs publicly available on this website. They include the synopsis of the CSR submitted to the regulatory agency.

Any data that could be used to identify individual patients has been removed.  Synopses will be posted for trials either initiated after Sept. 27, 2007, or trials initiated on or before that date that were still ongoing as of Dec. 26, 2007. To access the synopses that have been posted to date, press the "Show Results" button to see the full list, or filter the results using the fields below.

 

 

Choose Brand Name
Choose Brand Name
Emblaveo
Ponsegromab
Abrilada (PF-06410293)
ABRYSVO
Advil
Advil Dual Action with Acetaminophen
Advil Lift
ALO-02
Aricept
Aromasin
Avinza
Azulfidine
Bavencio
Bazedoxifene
BeneFIX
Besponsa
Bosulif
Braftovi
Braftovi and Mektovi
Braftovi, Mektovi
Caduet
Camptosar
Caverject
Ceftazidime-Avibactam
Celebrex
Chantix
Cibinqo
Clostridium Difficile Vaccine
Comirnaty
CTDG TESTING SCRIPT Fragmin®
Cyklokapron
Daurismo
Detrol
Diflucan
Domagrozumab
Duavee
Dynastat
Effexor XR
Eliquis
Elranatamab
Embeda
Enbrel
Epoetin Hospira
Eraxis
Eucrisa
Exubera
Flagyl
Flector Patch
Fragmin
FSME-IMMUN
Genotonorm
Genotropin
Geodon
Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine (GBS6)
Ibrance
Imedeen
Inclacumab
InductOs
Inlyta
Inspra
Kerydin
Lipitor
LITFULO
Lorazepam
Lorbrena
Lotiglipron
Lyrica
Macugen
MekTovi
Minipress
Mobic
MultiStem
Mylotarg
Neumega
Neurontin
Nimenrix
Norvasc
Nurtec ODT
Nyvepria
Patrex
Paxlovid
PF-07284890
Ponsegromab
Precedex
Prevenar 13
Prevnar 13
Prevnar 20
Prevnar 7
Pristiq
Protonix
Rapamune
ReFacto AF
Relistor
Revatio
Robitussin
RSVpreF
Ruxience
Sayana Press
Selzentry
Somatrogon
Spiriva
Sutent
Talzenna
Tanezumab
Thermacare Heat Wraps
Torisel
Toviaz
Trastuzumab
Trazimera
Troxyca
Trumenba
TUKYSA
Tygacil
Tygacil
Unasyn-S
Velsipity
Vfend
Viagra
Vizimpro
Vyndaqel
Xalacom
Xalatan
Xalkori
Xeljanz
Xiapex
Xtandi
Xyntha
Zavicefta
Zavzpret™
Zavzpret™
Zimlovisertib
Zinforo
Zirabev
Zithromax
Zoloft
Zyvox
Generic Name
Generic Name
PF-06946860
PF-07817883
Rimegepant
13-Valent pneumococcal conjugate vaccine
13-valent Pneumococcal Conjugate Vaccine (13vPnC)
20-valent pneumococcal conjugate vaccine
7-Valent pneumococcal conjugate vaccine
abrocitinib
Adalimumab Pfizer
alprostadil
amlodipine
amlodipine/atorvastatin
anidulafungin
APD418 (PF-07915504)
apixaban
atorvastatin
avelumab
axitinib
azithromycin
Aztreonam-Avibactam (ATM-AVI)
bazedoxifene acetate
bazedoxifene, conjugated estrogens
bevacizumab
binimetinib
BNT162b2
bococizumab
bosutinib
brepocitinib
caffeine with ibuprofen
ceftaroline fosamil
ceftazidime – avibactam
Ceftazidime-Avibactam
celecoxib
collagenase
complementary 7-valent pneumococcal conjugate vaccine, PF-06842433
cp-074859
crisaborole
crizotinib
CTDG TESTING SCRIPT dalteparin
dacomitinib
dalteparin
dalteparin sodium
danuglipron
dekavil
desvenlafaxine succinate
dexmedetomidine
dextromethorphan
dibotermin alfa
diclofenac epolamine
donepezil
encorafenib
encorafenib, binimetinib
enzalutamide
eplerenone
ervogastat (PF-06865571)
ervogastat and clesacostat
etanercept
etrasimod
exemestane
fesoterodine
fezakinumab
fidanacogene elaparvovec
figitumumab
fluconazole
fordadistrogene movaparvovec
fosdagrocorat
fosmanogepix
gabapentin
gedatolisib
gemtuzumab ozogamicin
glasdegib
guaifenesin
ibuprofen 5% topical gel
ibuprofen sodium
ibuprofen;paracetamol
ILV-095
inhaled human insulin
inotuzumab ozogamicin
inotuzumab ozogamicin
irinotecan
latanoprost
linezolid
lorlatinib
maplirpacept
maraviroc
marstacimab (PF-06741086)
medroxyprogesterone acetate
meloxicam
Meningococcal group B vaccine
meningococcal serogroup b vaccine
meningococcal vaccine a/c/y/w conj
meningococcal vaccine pentavalent
methylnaltrexone bromide
metronidazole
moroctocog alfa
morphine sulfate
morphine sulfate and naltrexone hydrochloride
nirmatrelvir
Nirmatrelvir/Ritonavir
nonacog alfa
ontorpacept
oprelvekin
osivelotor
oxycodone hydrochloride and naltrexone hydrochloride
palbociclib
pantoprazole sodium
parecoxib sodium
PD-0360324
pegaptanib
pegfilgrastim-apgf
PF-00299804
PF-00345101
PF-00489791
PF-02545920
PF-03084014
PF-03446962
PF-03715455
PF-04136309
PF-04191834
PF-04236921
PF-04383119
PF-04447943
PF-04457845
PF-04518600
PF-04531083
PF-04605412
PF-04634817
PF-04691502
PF-04937319
PF-04958242
PF-05089771
PF-05175157
PF-05212377
PF-05221304
PF-05230907
PF-05231023
PF-05280014
PF-05280586
PF-05285401
PF-06252616
PF-06263507
PF-06290510
PF-06291874
PF-06293620
PF-06342674
PF-06425090
PF-06439535 /bevacizumab
PF-06444753 and PF-06444752
PF-06480605
PF-06647020
PF-06647263
PF-06650808
PF-06650833
PF-06650833_PF-06700841_PF-06826647
PF-06664178
PF-06669571
PF-06671008
PF-06700841
PF-06730512
PF-06743649
PF-06747143
PF-06747775
PF-06753512
PF-06755347
PF-06760805
PF-06763809
PF-06804103
PF-06817024
PF-06821497
PF-06823859
PF-06826647
PF-06830414
PF-06835375
PF-06835919
PF-06836922
PF-06840003
PF-06863135
PF-06865571
PF-06873600
PF-06928316
PF-06936308
PF-06939999
PF-06946151
PF-06946860
PF-06947386
PF-06952229
PF-07038124
PF-07062119
PF-07081532
PF-07104091
PF-07202954
PF-07209326
PF-07209960
PF-07242813
PF-07252220
PF-07258669
PF-07258669
PF-07260437
PF-07261271
PF-07263689
PF-07265028
PF-07265803
PF-07295324 and PF-07259955
PF-07304814
PF-07321332/nirmatrelvir
PF-07328948
PF-07612577
PF-07817883
PF-07831695
PF-07915503 (APD334)
PF-07926307 (Combination COVID-19 and Influenza modRNA Vaccine)
PF-07940370
PF-07941314
PF-08046046 (SGN-ALPV)
prazosin hydrochloride
pregabalin
recifercept
Rimegepant
ritlecitinib
ritlecitinib (PF-06651600)
rituximab
Sasanlimab (PF-06801591)
sertraline
sildenafil
sildenafil citrate
sirolimus
sirolimus
sisunatovir
sitaxsentan sodium
somatropin
somatropin
sulfasalazine
sunitinib malate
sunitinib malate
tafamidis
tafamidis
tafamidis meglumine
talazoparib
tavaborole
temanogrel
temsirolimus
temsirolimus
tick-borne encephalitis vaccine
tigecycline
tigecycline
timolol maleate
tinlorafenib
tiotropium
tofacitinib
tolterodine
tranexamic acid
trastuzumab
Tucatinib
utomilumab
varenicline
varenicline tartrate
varenicline tartrate
venlafaxine hydrochloride
vepdegestrant
voriconazole
vupanorsen (PF-07285557)
zavegepant
ziprasidone
ziprasidone
Study Phase
Study Phase
PHASE I
PHASE II
PHASE III
PHASE IV
E.g., 2020-01-24
E.g., 2020-01-24
E.g., 2020-01-24
E.g., 2020-01-24
Select any filter and click on Apply to see results

* The NCT Number is the ClinicalTrials.gov unique identifier for a specific study.

Pfizer’s practices adhere to the principles for responsible data sharing laid out by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).